Published in Biophys J on September 30, 2005
Loop modeling: Sampling, filtering, and scoring. Proteins (2008) 1.81
Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors. Proteins (2010) 1.27
Mechanism of signal propagation upon retinal isomerization: insights from molecular dynamics simulations of rhodopsin restrained by normal modes. Biophys J (2008) 1.18
Membrane protein prediction methods. Methods (2007) 1.17
How a small change in retinal leads to G-protein activation: initial events suggested by molecular dynamics calculations. Proteins (2007) 0.86
Progress in elucidating the structural and dynamic character of G Protein-Coupled Receptor oligomers for use in drug discovery. Curr Pharm Des (2009) 0.85
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening. J Med Chem (2008) 0.85
Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors. Expert Opin Drug Discov (2008) 0.81
Structure prediction of the second extracellular loop in G-protein-coupled receptors. Biophys J (2014) 0.80
Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor. Proteins (2010) 0.79
Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking. BMC Biophys (2014) 0.78
Defining the interface between the C-terminal fragment of alpha-transducin and photoactivated rhodopsin. Biophys J (2007) 0.77
The cytoplasmic rhodopsin-protein interface: potential for drug discovery. Curr Drug Targets (2012) 0.76
Conserved residues in the extracellular loops of short-wavelength cone visual pigments. Biochemistry (2011) 0.76
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol (2003) 9.99
Modeling of loops in protein structures. Protein Sci (2000) 9.68
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (1996) 6.50
A hierarchical approach to all-atom protein loop prediction. Proteins (2004) 5.18
Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev (2000) 4.98
Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A (2002) 4.12
Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry (2001) 3.62
Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv Protein Chem (2003) 3.28
Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction. Proc Natl Acad Sci U S A (2002) 3.23
Distance measurements in the nanometer range by pulse EPR. Chemphyschem (2002) 2.50
Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry (2003) 2.42
Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol (2001) 2.38
Ab initio construction of polypeptide fragments: efficient generation of accurate, representative ensembles. Proteins (2003) 1.56
Structure and function in rhodopsin: effects of disulfide cross-links in the cytoplasmic face of rhodopsin on transducin activation and phosphorylation by rhodopsin kinase. Biochemistry (1999) 1.08
Topographical requirements for delta-selective opioid peptides. Biopolymers (1991) 1.06
Ab initio modeling of small, medium, and large loops in proteins. Biopolymers (2001) 1.05
Key issues in the computational simulation of GPCR function: representation of loop domains. J Comput Aided Mol Des (2002) 1.04
Rhodopsin-transducin interface: studies with conformationally constrained peptides. Biophys J (2001) 0.99
Discrimination of native loop conformations in membrane proteins: decoy library design and evaluation of effective energy scoring functions. Proteins (2003) 0.93
Dynamics in rhodopsin. Chembiochem (2002) 0.88
Computational molecular modeling in peptide drug design. Int J Pept Protein Res (1994) 0.87
Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor. Biochemistry (2003) 0.85
Modelling of third cytoplasmic loop of bovine rhodopsin by multicanonical molecular dynamics. J Mol Graph Model (2004) 0.81
The biology and future prospects of antivirulence therapies. Nat Rev Microbiol (2008) 3.83
A crowdsourcing evaluation of the NIH chemical probes. Nat Chem Biol (2009) 2.29
Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors. Proteins (2010) 1.27
Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP response regulator. Chem Biol Drug Des (2012) 0.98
Development of small molecules designed to modulate protein-protein interactions. J Comput Aided Mol Des (2006) 0.97
Protein recognition motifs: design of peptidomimetics of helix surfaces. Biopolymers (2007) 0.95
Conformational manifold of alpha-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular dichroism spectroscopy, and molecular dynamics simulations. J Am Chem Soc (2007) 0.92
Impact of cis-proline analogs on peptide conformation. Biopolymers (2006) 0.91
Virtual screening for lead discovery. Methods Mol Biol (2011) 0.91
Electron paramagnetic resonance studies of functionally active, nitroxide spin-labeled peptide analogues of the C-terminus of a G-protein alpha subunit. Biochemistry (2010) 0.91
A virtual library of constrained cyclic tetrapeptides that mimics all four side-chain orientations for over half the reverse turns in the protein data bank. J Comput Aided Mol Des (2008) 0.90
Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor. Biochemistry (2008) 0.89
Relative strength of cation-pi vs salt-bridge interactions: the Gtalpha(340-350) peptide/rhodopsin system. J Am Chem Soc (2006) 0.88
PHOENIX: a scoring function for affinity prediction derived using high-resolution crystal structures and calorimetry measurements. J Chem Inf Model (2011) 0.87
G-protein alpha and beta-gamma subunits interact with conformationally distinct signaling states of rhodopsin. Vision Res (2006) 0.86
Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor. Biochemistry (2003) 0.85
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening. J Med Chem (2008) 0.85
Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups. Biopolymers (2008) 0.85
Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor. Chem Biol Drug Des (2006) 0.85
Conformationally restricted TRH analogues: constraining the pyroglutamate region. Bioorg Med Chem (2002) 0.84
Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chem Biol Drug Des (2006) 0.84
Motion of carboxyl terminus of Galpha is restricted upon G protein activation. A solution NMR study using semisynthetic Galpha subunits. J Biol Chem (2005) 0.84
Hydroxamate-based iron chelators: combinatorial syntheses of desferrioxamine B analogues and evaluation of binding affinities. J Comb Chem (2004) 0.83
Privileged scaffolds targeting reverse-turn and helix recognition. Expert Opin Ther Targets (2008) 0.82
Modeling of the complex between transducin and photoactivated rhodopsin, a prototypical G-protein-coupled receptor. Biochemistry (2007) 0.82
Molecular dynamics of β-hairpin models of epigenetic recognition motifs. J Am Chem Soc (2012) 0.82
Engineering cyclic tetrapeptides containing chimeric amino acids as preferred reverse-turn scaffolds. J Med Chem (2006) 0.81
Synthesis of the phenylpyridal scaffold as a helical peptide mimetic. Chemistry (2010) 0.81
Histone deacetylase inhibitors: structure-based modeling and isoform-selectivity prediction. J Chem Inf Model (2012) 0.81
Do benzodiazepines mimic reverse-turn structures? J Comput Aided Mol Des (2006) 0.81
Drug-like leads for steric discrimination between substrate and inhibitors of human acetylcholinesterase. Chem Biol Drug Des (2011) 0.81
SKATE: a docking program that decouples systematic sampling from scoring. J Comput Chem (2010) 0.80
Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination. Biopolymers (2006) 0.80
Alternate binding mode of C-terminal phenethylamine analogs of G(t)alpha(340-350) to photoactivated rhodopsin. Chem Biol Drug Des (2006) 0.80
Difference between restoring and predicting 3D structures of the loops in G-protein-coupled receptors by molecular modeling. Proc Natl Acad Sci U S A (2011) 0.80
Expressed protein ligation to study protein interactions: semi-synthesis of the G-protein alpha subunit. Protein Pept Lett (2005) 0.80
ProVal: a protein-scoring function for the selection of native and near-native folds. Proteins (2004) 0.79
A second look at mini-protein stability: analysis of FSD-1 using circular dichroism, differential scanning calorimetry, and simulations. Biophys J (2009) 0.79
Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors. Chem Biol Drug Des (2010) 0.79
Conformational templates for rational drug design: flexibility of cyclo(D-Pro1-Ala2-Ala3-Ala4-Ala5) in DMSO solution. J Med Chem (2007) 0.79
Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor. Proteins (2010) 0.79
Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors. Chem Biol Drug Des (2007) 0.79
Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors. Bioorg Med Chem (2002) 0.78
Peptide-bond modification for metal coordination: peptides containing two hydroxamate groups. Biopolymers (2003) 0.78
Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCR. Chem Biol Drug Des (2010) 0.78
3D modeling of the activated states of constitutively active mutants of rhodopsin. Biochem Biophys Res Commun (2006) 0.78
Impact of azaproline on Peptide conformation. J Org Chem (2004) 0.77
Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents. Bioorg Med Chem Lett (2003) 0.77
Defining the interface between the C-terminal fragment of alpha-transducin and photoactivated rhodopsin. Biophys J (2007) 0.77
Helix stability of oligoglycine, oligoalanine, and oligo-β-alanine dodecamers reflected by hydrogen-bond persistence. Proteins (2014) 0.76
Comprehensive model of wild-type and mutant HIV-1 reverse transciptases. J Comput Aided Mol Des (2012) 0.76
Impact of azaproline on amide cis-trans isomerism: conformational analyses and NMR studies of model peptides including TRH analogues. J Am Chem Soc (2003) 0.76
A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists. Biopolymers (2006) 0.76
Engineering metal complexes of chiral pentaazacrowns as privileged reverse-turn scaffolds. Chem Biol Drug Des (2007) 0.76
Metal complexes of chiral pentaazacrowns as conformational templates for beta-turn recognition. J Comput Aided Mol Des (2003) 0.75
c[D-pro-Pro-D-pro-N-methyl-Ala] adopts a rigid conformation that serves as a scaffold to mimic reverse-turns. Biopolymers (2008) 0.75
Validated ligand mapping of ACE active site. J Comput Aided Mol Des (2005) 0.75